72 results on '"Izumi, Tohru"'
Search Results
2. Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure
3. Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease
4. Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF
5. Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial
6. Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation for the Secondary Prevention of Stroke: A Subgroup Analysis of J-ROCKET AF
7. Effect of persistent activation of phosphoinositide 3-kinase on heart
8. The Effects of Depression on the Course of Functional Limitations in Patients With Chronic Heart Failure
9. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
10. Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure
11. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis
12. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure
13. Retrospective analysis on 20 relapsed or refractory cases of multiple myeloma treated by panobinostat with subcutaneous bortezomib
14. O5-8 - Differences, If Any, in Prognostic Indicators of Heart Failure: Comparison between Octogenarians and Nonagenarians
15. SY3-4 - An Approach for Super-Elderly Patients With Heart Failure and Frailty in Community Hospital: DOPPO Rehabilitation
16. 70% of Elderly Patients Got Total SPPB Score Over 9 Points after Rehabilitation Achieve a 6-min Walk Distance Over 300m
17. Comprehensive Strategy Using Mechanical Cardiac Support for a Dilated Cardiomyopathy Patient with Intolerable Heart Failure Condition
18. A Case of Female Danon Disease with Rapidly-deteriorated Heart Failure Heading for Heart Transplantation
19. Infarct Size and Ventricular Dilatation for 4 Weeks After the Onset of Acute Myocardial Infarction Determines Prominent Left Ventricular Remodeling
20. High Glucose-induced Cell Migration, Proliferation and Up-regulation of Growth Factor Signalings are Accelerated by ROS Produced by Cardiac Fibroblasts
21. Clinical Significance of Cardiovascular Magnetic Resonance Imaging in Predicting Long-term Prognosis and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy
22. A Case of Left Heart Failure Late after Repair of Tetralogy of Fallot
23. Surveillance and Prospective Study for the Candidates to Life-Long Support by Ventricular Assist Device in Japan: Second Report
24. Role of Hematopoietic Stem Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated with All-Trans-Retinoic Acid: A Retrospective Analysis of the Japan Adult Leukemia Study Group (JALSG) APL97 Study
25. Clinical Benefit of CRT and his Bundle Ablation in Patient with Repeated Heart Failure Exacerbation Coincident with Transient AF
26. Clinical Significance of Heart Rate at Heart Failure Exacerbation to Predict Reverse Left Ventricular Remodeling
27. First-pass Perfusion Defect of the Subendocardium by Cardiac Magnetic Resonance Indicates the Microvascular Myocardial Ischemia
28. Lupus Myocarditis Presenting as Acute Severe Heart Failure: Two Cases with Different Clinical Courses
29. Association between Pentraxin 3 and Renal Function in Patients at High Risk of Cardiovascular Disease
30. Prognostic Significance of Cardiac Power Index on Decompensation in Chronic Heart Failure
31. A Clinical Pharmacological Study of Tolvaptan in the Heart Failure Patients With Volume Overload
32. An Open-Label Study of Tolvaptan in the Heart Failure Patients With Volume Overload
33. Sub-Group Analysis of the QUEST Study -Qualification of Efficacy and Safety in the Study of Tolvaptan in Cardiac Edema
34. A Dose-Ranging Study of Tolvaptan in Heart Failure Patients With Volume Overload
35. Clinical Benefit of Cardiac-Resynchronization Therapy in a Patient With Repeated Heart Failure Exacerbation Coincident With Intermittent Left Bundle Branch Block
36. A Case of Acute-Onset Heart Failure Derived from Infective Endocarditis Coinciding With H1N1 Influenza Myocarditis
37. Clinical Impact of Corticosteroid Therapy on Eosinophilic Myocarditis
38. Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients with Non-Ischemic Cardiomyopathy after Decompensated Heart Failure
39. Serum Interleukin−10 Predict Fatality in Acute Myocardial Infarction Complicated by Cardiogenic Shock
40. Insulin signaling plays a critical role in cardiac aging
41. A case of cardiac sarcoidosis with spontaneous remission and re-exacerbation
42. ST-T changes during bepridil therapy may be affected by the presence of structural heart disease
43. Significance of end tidal carbon dioxide to predict clinical recovery in patients with percutaneous cardiopulmonary support
44. Delta-HR/delta-MET at submaximal exercise reflects exercise capacity in patients with ischemic heart disease.
45. MRI Findings in Non-ischemic Heart Failure
46. Long-term Benefits of Nocturnal Oxygen Therapy in Patients with Chronic Heart Failure and Central Sleep Apnea
47. Characteristics of Balance Function in Heart Failure Patients Undergoing a Phase I Cardiac Rehabilitation
48. Role of ICD in Prevention of Sudden Cardiac Death in Heart Failure
49. Immunomodulatory Effects of Inhibitory G-protein Signals Antagonism in Experimental Autoimmune Myocarditis
50. How can we Deal with Arrhythmia in Myocarditis? - Optimal-adequate Management of Fatal Arrhythmia Complicated in Fulminant Myocarditis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.